SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 7, 2008, Pages 1226-1228

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake: A pilot study

(4) Sconce, E A a,b Avery, P J a Wynne, H A b Kamali, Farhad a,b

a NEWCASTLE UNIVERSITY (United Kingdom)

b NEWCASTLE UNIVERSITY (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENADIONE EPOXIDE; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE INCREASE; EVENING DOSAGE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; PILOT STUDY; POLYMERASE CHAIN REACTION; POST HOC ANALYSIS; PRIORITY JOURNAL; SIGNAL NOISE RATIO; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; PILOT PROJECTS; POLYMORPHISM, GENETIC; VITAMIN K; WARFARIN;

EID: 45549086490 PISSN: 15387933 EISSN: 15387836 Source Type: Journal
DOI: 10.1111/j.1538-7836.2008.03003.x Document Type: Article

Times cited : (14)

References (7)

1
- 33947202312
- Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin
- Sconce EA, Avery P, Wynne HA, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-23.
- (2007) Blood , vol.109 , pp. 2419-2423
- Sconce, E.A.¹ Avery, P.² Wynne, H.A.³ Kamali, F.⁴

2
- 23044440450
- The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen
- Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP, Wood P, Kesteven P, Daly AK, Kamali F. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen. Blood 2005; 106: 2329-33.
- (2005) Blood , vol.106 , pp. 2329-2333
- Sconce, E.A.¹ Khan, T.I.² Wynne, H.A.³ Avery, P.⁴ Monkhouse, L.⁵ King, B.P.⁶ Wood, P.⁷ Kesteven, P.⁸ Daly, A.K.⁹ Kamali, F.¹⁰

3
- 21144448879
- Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
- Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285-93.
- (2005) N Engl J Med , vol.352 , pp. 2285-2293
- Rieder, M.J.¹ Reiner, A.P.² Gage, B.F.³ Nickerson, D.A.⁴ Eby, C.S.⁵ McLeod, H.L.⁶ Blough, D.K.⁷ Thummel, K.E.⁸ Veenstra, D.L.⁹ Rettie, A.E.¹⁰

4
- 0034775808
- Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans
- Kamali F, Edwards C, Wood P, Wynne HA, Kesteven P. Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans. Am J Hematol 2001; 68: 159-63.
- (2001) Am J Hematol , vol.68 , pp. 159-163
- Kamali, F.¹ Edwards, C.² Wood, P.³ Wynne, H.A.⁴ Kesteven, P.⁵

5
- 4143140928
- Determination of phylloquinone (vitamin K1) in plasma and serum by HPLC with fluoresence detection
- Wang LY, Bates CJ, Yan L, Harrington DJ, Shearer MJ, Prentice A. Determination of phylloquinone (vitamin K1) in plasma and serum by HPLC with fluoresence detection. Clin Chim Acta 2004; 347: 199-207.
- (2004) Clin Chim Acta , vol.347 , pp. 199-207
- Wang, L.Y.¹ Bates, C.J.² Yan, L.³ Harrington, D.J.⁴ Shearer, M.J.⁵ Prentice, A.⁶

6
- 0023899986
- The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin
- Choonara IA, Malia RG, Haynes BP, Hay CR, Cholerton S, Breckenridge AM, Preston FE, Park BK. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Pharmacol 1988; 25: 1-7.
- (1988) Br J Clin Pharmacol , vol.25 , pp. 1-7
- Choonara, I.A.¹ Malia, R.G.² Haynes, B.P.³ Hay, C.R.⁴ Cholerton, S.⁵ Breckenridge, A.M.⁶ Preston, F.E.⁷ Park, B.K.⁸

7
- 33746670024
- Genetic influences on the response to warfarin
- Kamali F. Genetic influences on the response to warfarin. Curr Opin Hematol 2006; 13: 357-61.
- (2006) Curr Opin Hematol , vol.13 , pp. 357-361
- Kamali, F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.